Fei is the Director of Biology and Discovery at SEED. He has 19 years of experience in drug discovery and development. At SEED, he focuses on leading HTS, hit-to-lead, and lead optimization efforts for small molecules targeting viral and tumor pathways.
Before joining SEED, he conducted IND-enabling studies for HBV RNA destabilizers at Arbutus Biopharma and discovered novel HBV capsid assembly modulators during his postdoc research that were licensed to Arbutus Biopharma for further clinical development. Fei holds a Ph.D. in Microorganisms and Biochemical Pharmacy from the Chinese Academy of Medical Sciences and Peking Union Medical College.